Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients After Diagnostic and Therapeutic Cardiac Catheterization (IDPC Trial)

NCT02991742 is registered in ClinicalTrials.gov with Instituto Dante Pazzanese de Cardiologia as lead sponsor.

NCT NCT02991742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02991742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients After Diagnostic and Therapeutic Cardiac Catheterization (IDPC Trial)
Lead sponsor
Instituto Dante Pazzanese de Cardiologia
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2016
Completion date
November 30, 2020
Enrollment
2,262 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney failure